Filter
2247
Filtered Results: 2247
Text search:
health
worker
retention
Featured
Recommendations
182
New Publications
652
Language
Document type
No document type
1422
Studies & Reports
314
Guidelines
242
Manuals
97
Strategic & Response Plan
78
Fact sheets
32
Training Material
31
Situation Updates
19
Brochures
4
Infographics
4
Resource Platforms
3
Online Courses
1
Countries / Regions
Kenya
89
India
74
Global
70
South Africa
70
Uganda
67
Western and Central Europe
58
Nigeria
51
Malawi
49
Zambia
48
Syria
44
Liberia
41
Nepal
39
Sierra Leone
39
Ethiopia
39
Myanmar / Burma
37
Bangladesh
32
Tanzania
31
Rwanda
30
Namibia
27
Lesotho
26
Zimbabwe
26
Africa
26
Ghana
25
South Sudan
25
Mozambique
23
Ukraine
22
Botswana
20
Indonesia
20
Asia
19
Latin America and the Carribbean
19
Congo, Democratic Republic of
17
Eastern Europe
16
Senegal
14
Venezuela
13
South–East Asia Region
13
Yemen
12
Eswatini/ Swaziland
11
East and Southern Africa
10
Russia
10
Burkina Faso
9
Afghanistan
9
Philippines
9
Guinea
9
Eastern Europe and Central Asia
9
Pakistan
9
Tajikistan
8
Cambodia
8
Vietnam
8
Cameroon
7
Germany
7
Brazil
7
Georgia
7
Albania
6
Lebanon
6
Central African Republic
6
Libya
6
Colombia
5
West and Central Africa
5
Middle East and North Africa
5
Southern Africa
5
Moldova
5
North Macedonia
4
Thailand
4
Turkey
4
Haiti
4
Jordan
4
Sri Lanka
4
Sudan
4
Mali
4
Iraq
4
Mexico
3
Benin
3
China
3
Iran
3
Laos
3
Kyrgyzstan
3
Croatia
3
Portugal
3
Papua New Guinea
3
Greece
3
Palestine
3
Timor Leste/ East Timor
2
Estonia
2
Niger
2
Burundi
2
Peru
2
Italy
2
Armenia
2
USA
2
Hungary
2
Turkmenistan
2
United Kingdom
2
Spain
2
Argentina
2
Poland
2
Somalia
2
Serbia
1
Gambia
1
Kazakhstan
1
Chile
1
Canada
1
Fiji
1
Singapore
1
Malaysia
1
Morocco
1
Paraguay
1
Jamaica
1
Japan
1
Belgium
1
France
1
Tunisia
1
Norway
1
Algeria
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Egypt
1
Angola
1
Bhutan
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
922
Women & Child Health
129
Clinical Guidelines
110
Public Health
109
Key Resources
106
Capacity Building
60
Pharmacy & Technologies
10
Toolboxes
HIV
361
COVID-19
162
Mental Health
150
TB
132
Conflict
91
Refugee
84
Caregiver
83
Disability
65
Global Health Education
31
Planetary Health
27
Ebola & Marburg
26
Pharmacy
23
NCDs
22
NTDs
20
Rapid Response
18
Natural Hazards
18
AMR
11
Health Financing Toolbox
10
Polio
8
Specific Hazards
6
Malaria
5
Cholera
4
South Sudan
2
Social Ethics
2
Zika
2
The immediate objective of the country visit to Cameroon was to ensure that the country is as operationally ready as possible to effectively and safely detect, investigate and report potential Ebola virus disease cases and to mount an effective response that will prevent a larger outbreak. After te...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi...
17–24 November 2015
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
Technical Brief
Damon Barrett, Gonçalo Figueiredo Augusto, Martiani Oktavia, Jeanette Olsson, Mira Schneiders and Kate Welch provided background papers and literature reviews which informed this technical series.
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Refugees and migrants face similar health threats from COVID-19 as their host populations. However, inadequate access to essential services and exclusion may makes early detection, testing, diagnosis, contact tracing and seeking care for COVID-19 difficult for refugees and migrants thus increasing t...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
The END TB Strategy
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
A manual for programme managers.
БОРЬБА С ТУБЕРКУЛЕЗОМ В ТЮРЬМАХ
Руководство для руководителей программ
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
The purpose of this document is to provide guidance on the cleaning and disinfection of environmental surfaces in the context of COVID-19. This guidance is intended for health care professionals, public health professionals and health authorities that are developing and implementing policies and sta...
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...
Q&A on COVID-19, HIV and antiretrovirals - Hỏi Đáp về COVID-19, HIV và thuốc antiretrovirals (ARVs)
